News & Insights | Compliance & Legal, Biotech & Pharma

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Emerging business models in specialty pharmaceuticals

Navigating compliance strategy and day-to-day concerns

Report: The future of artificial intelligence in compliance

Elevating the compliance officer’s role

What & How: Lessons from Spend Transparency & Their Direct Application to Pricing Transparency

Post-event Report eBook: Pharmaceutical Compliance Congress

Compliance Webcast: Pharma and MedTech Compliance — Industry Guidance for Emerging Trends & Best Practices for the Year Ahead

Hot Topics in Pharma and Biotech: An interview with Eva Temkin

PCC 2023: Current Pharmaceutical Compliance Trends and Analysis from Deloitte's Paul Silver

PCC 2023: AI, Privacy, and Pharmaceutical Compliance

PCC 2023: Compliance with Charitable Patient Assistance Foundations

Modernization Monopoly: How to Pass Go and Invest in your Organization's Future

Next Gen Compliance: Data Analytics and Automation - PwC Moore

Next Gen Compliance: Data Analytics and Automation

Transparency 2021 Year in Review and 2022 Preview | MedPro SYSTEMS

"With tighter operating margins, we will see more payers pressuring pharmaceutical manufacturers to guarantee their products improve patient outcomes" - Darren Jones, Baker Tilly

Transparency & Aggregate Spend Benchmarking Report 2021

Best Guidance for Managing Risks and Avoiding Enforcement Actions | Porzio Life Sciences

"With tighter operating margins, we will see more payers pressuring pharmaceutical manufacturers to guarantee their products improve patient outcomes" - Darren Jones, Baker Tilly

State of the Industry — Critical Bio/Pharma Policy Updates for Compliance After COVID | Covington

Quick Links